Human PilotPubMed ID: 15045685·2004

Sermorelin Stimulates Growth Hormone Secretion in Older Adults Independent of Body Mass Index

Hoffman RP, Licinio J, Mosley TH, et al.

Metabolism, 2004 · n = 54

Key finding

Sermorelin response was preserved in obese versus normal-weight adults (IGF-1 increase 162% vs 179%, p=NS).

Summary

Study examining sermorelin responsiveness across BMI categories, testing whether obesity impairs GHRH-mediated GH secretion.

Read the study

The full citation, abstract, and (when available) the full text can be accessed on PubMed. PeptideMark summaries are condensed overviews — we encourage researchers to read primary sources.

View on PubMed

Related compound

SermorelinL4

A growth hormone-releasing hormone analog with a long history of clinical use for GH deficiency diagnosis and therapy.

More research on Sermorelin

Sermorelin Acetate Administration Increases Mean Plasma GH Levels and Reduces Waist Circumference in Obese Men

Journal of Clinical Endocrinology & Metabolism · 2005 · Human RCT

Sermorelin Acetate in the Treatment of Age-Related Growth Hormone Deficiency: A Randomized Controlled Trial

Aging Clinical and Experimental Research · 2003 · Human RCT

Sermorelin Improves Insulin Secretion and Glucose Tolerance in Older Subjects with Impaired Fasting Glucose

Journal of Clinical Endocrinology & Metabolism · 2002 · Human RCT

Sermorelin Restores Bone Mineral Density in Growth Hormone-Deficient Adults: A 2-Year Randomized Trial

Journal of Clinical Endocrinology & Metabolism · 2002 · Human RCT

GHRH Analog Sermorelin Effects on Body Composition, Lipolysis, and Metabolic Parameters in Older Men

Journal of Gerontology: Biological Sciences · 2001 · Human RCT